Skip to main content
Erschienen in: Inflammation 5/2021

20.05.2021 | Original Article

PD-L1 Regulates Inflammation in LPS-Induced Lung Epithelial Cells and Vascular Endothelial Cells by Interacting with the HIF-1α Signaling Pathway

verfasst von: Shilong Zhao, Jing Gao, Jing Li, Shilei Wang, Congcong Yuan, Qiuhong Liu

Erschienen in: Inflammation | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Sepsis-induced lung injury was the most common cause of death in patients. This study aimed to investigate whether PD-L1 regulates the inflammation in LPS-induced lung epithelial cells and vascular endothelial cells by interacting with the HIF-1α signaling pathway. Sepsis-induced lung injury mice were constructed by cecal ligation and puncture (CLP) procedure, and lipopolysaccharide (LPS)-induced lung epithelial cells and vascular endothelial cells simulate the sepsis-induced lung injury model in vitro. Hematoxylin-eosin (HE) staining detected the morphological changes of the lung tissues, and immunohistochemistry (IHC) detected the PD-L1 expression in lung tissues. Bicinchoninic acid (BCA) assay determined the protein concentration in bronchial alveolar lavage fluid (BALF). The number of PD-1 (+) cells in blood was detected by flow cytometry. The apoptosis in lung tissues and LPS-induced cells was analyzed by TUNEL assay. The inflammatory factor levels and HIF-1α in lung tissues and LPS-induced cells were analyzed by ELISA. The transfection effects of KD-PDL1 or KD-HIF1A in lung epithelial cells and vascular endothelial cells were confirmed by qRT-PCR analysis. The protein expression related to the PD-L1- and HIF-1α-related pathway was determined by Western blot analysis. As a result, LMT-28, as an IL-6 inhibitor, alleviated lung injury and suppressed the apoptosis and inflammation in lung tissues in BALF and the number of PD-1 (+) cells in blood. Sepsis-induced lung injury activated the PD-L1- and HIF-1α-related pathway, while LMT-28 could not completely inhibit the pathway. In addition, downregulation of PD-L1 or downregulation of HIF-1α suppressed the apoptosis and alleviated the inflammation in LPS-induced lung epithelial cells and vascular endothelial cells. Downregulation of PD-L1 had significant effects on lung epithelial cells but had greater effects on vascular endothelial cells. Downregulation of HIF-1α could decrease PD-L1 expression, and downregulation of PD-L1 could also suppress the protein expression of HIF-1α and related pathways. In conclusion, downregulation of PD-L1 alleviated the inflammation in LPS-induced lung epithelial cells and vascular endothelial cells by suppressing the HIF-1α signaling pathway.
Literatur
1.
Zurück zum Zitat Singer, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, et al. 2016. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315: 801–810.PubMedPubMedCentralCrossRef Singer, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, et al. 2016. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315: 801–810.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Bellani, G., J.G. Laffey, T. Pham, E. Fan, L. Brochard, A. Esteban, et al. 2016. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315: 788–800.PubMedCrossRef Bellani, G., J.G. Laffey, T. Pham, E. Fan, L. Brochard, A. Esteban, et al. 2016. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315: 788–800.PubMedCrossRef
3.
Zurück zum Zitat Fragoso, I.T., E.L. Ribeiro, F.O. Gomes, M.A. Donato, A.K. Silva, A.C. Oliveira, et al. 2017. Diethylcarbamazine attenuates LPS-induced acute lung injury in mice by apoptosis of inflammatory cells. Pharmacological Reports 69: 81–89.PubMedCrossRef Fragoso, I.T., E.L. Ribeiro, F.O. Gomes, M.A. Donato, A.K. Silva, A.C. Oliveira, et al. 2017. Diethylcarbamazine attenuates LPS-induced acute lung injury in mice by apoptosis of inflammatory cells. Pharmacological Reports 69: 81–89.PubMedCrossRef
4.
Zurück zum Zitat Hu, X., S. Liu, J. Zhu, and H. Ni. 2019. Dachengqi decoction alleviates acute lung injury and inhibits inflammatory cytokines production through TLR4/NF-κB signaling pathway in vivo and in vitro. Journal of Cellular Biochemistry 120: 8956–8964.PubMedCrossRef Hu, X., S. Liu, J. Zhu, and H. Ni. 2019. Dachengqi decoction alleviates acute lung injury and inhibits inflammatory cytokines production through TLR4/NF-κB signaling pathway in vivo and in vitro. Journal of Cellular Biochemistry 120: 8956–8964.PubMedCrossRef
5.
Zurück zum Zitat Lei, J., Y. Wei, P. Song, Y. Li, T. Zhang, Q. Feng, et al. 2018. Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammation and oxidative stress. European Journal of Pharmacology 818: 110–114.PubMedCrossRef Lei, J., Y. Wei, P. Song, Y. Li, T. Zhang, Q. Feng, et al. 2018. Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammation and oxidative stress. European Journal of Pharmacology 818: 110–114.PubMedCrossRef
6.
Zurück zum Zitat Keir, M.E., M.J. Butte, G.J. Freeman, and A.H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annual Review of Immunology 26: 677–704.PubMedCrossRef Keir, M.E., M.J. Butte, G.J. Freeman, and A.H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annual Review of Immunology 26: 677–704.PubMedCrossRef
7.
Zurück zum Zitat Lomas-Neira, J., S.F. Monaghan, X. Huang, E.A. Fallon, C.S. Chung, and A. Ayala. 2018. Novel role for PD-1:PD-L1 as mediator of pulmonary vascular endothelial cell functions in pathogenesis of indirect ARDS in mice. Frontiers in Immunology 9: 3030.PubMedCrossRef Lomas-Neira, J., S.F. Monaghan, X. Huang, E.A. Fallon, C.S. Chung, and A. Ayala. 2018. Novel role for PD-1:PD-L1 as mediator of pulmonary vascular endothelial cell functions in pathogenesis of indirect ARDS in mice. Frontiers in Immunology 9: 3030.PubMedCrossRef
8.
Zurück zum Zitat Sun, B., X. Li, G. Zheng, T. Dong, Y. Li, H. Li, et al. 2019. Blockade of programmed death-ligand 1 attenuates indirect acute lung injury in mice through targeting endothelial cells but not epithelial cells. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 31: 37–43.PubMed Sun, B., X. Li, G. Zheng, T. Dong, Y. Li, H. Li, et al. 2019. Blockade of programmed death-ligand 1 attenuates indirect acute lung injury in mice through targeting endothelial cells but not epithelial cells. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 31: 37–43.PubMed
9.
Zurück zum Zitat Taylor, C.T., and J.C. McElwain. 2010. Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans. Physiology (Bethesda, Md.) 25: 272–279. Taylor, C.T., and J.C. McElwain. 2010. Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans. Physiology (Bethesda, Md.) 25: 272–279.
10.
Zurück zum Zitat Eltzschig, H.K., D.L. Bratton, and S.P. Colgan. 2014. Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nature Reviews Drug Discovery 13: 852–869.PubMedCrossRef Eltzschig, H.K., D.L. Bratton, and S.P. Colgan. 2014. Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nature Reviews Drug Discovery 13: 852–869.PubMedCrossRef
11.
Zurück zum Zitat Semenza, G.L. 2009. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda, Md.) 24: 97–106. Semenza, G.L. 2009. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda, Md.) 24: 97–106.
12.
Zurück zum Zitat Eltzschig, H.K., and P. Carmeliet. 2011. Hypoxia and inflammation. The New England Journal of Medicine 364: 656–665.PubMedCrossRef Eltzschig, H.K., and P. Carmeliet. 2011. Hypoxia and inflammation. The New England Journal of Medicine 364: 656–665.PubMedCrossRef
13.
Zurück zum Zitat Ouyang, H., Y. Tan, Q. Li, F. Xia, X. Xiao, S. Zheng, et al. 2020. MicroRNA-208-5p regulates myocardial injury of sepsis mice via targeting SOCS2-mediated NF-κB/HIF-1α pathway. International Immunopharmacology 81: 106204.PubMedCrossRef Ouyang, H., Y. Tan, Q. Li, F. Xia, X. Xiao, S. Zheng, et al. 2020. MicroRNA-208-5p regulates myocardial injury of sepsis mice via targeting SOCS2-mediated NF-κB/HIF-1α pathway. International Immunopharmacology 81: 106204.PubMedCrossRef
14.
Zurück zum Zitat Chang, Y.L., C.Y. Yang, M.W. Lin, C.T. Wu, and P.C. Yang. 2016. High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma. European Journal of Cancer (Oxford, England : 1990) 60: 125–135.CrossRef Chang, Y.L., C.Y. Yang, M.W. Lin, C.T. Wu, and P.C. Yang. 2016. High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma. European Journal of Cancer (Oxford, England : 1990) 60: 125–135.CrossRef
15.
Zurück zum Zitat Chen, T.C., C.T. Wu, C.P. Wang, W.L. Hsu, T.L. Yang, P.J. Lou, et al. 2015. Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof. Oral Oncology 51: 1004–1010.PubMedCrossRef Chen, T.C., C.T. Wu, C.P. Wang, W.L. Hsu, T.L. Yang, P.J. Lou, et al. 2015. Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof. Oral Oncology 51: 1004–1010.PubMedCrossRef
16.
Zurück zum Zitat Barsoum, I.B., C.A. Smallwood, D.R. Siemens, and C.H. Graham. 2014. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Research 74: 665–674.PubMedCrossRef Barsoum, I.B., C.A. Smallwood, D.R. Siemens, and C.H. Graham. 2014. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Research 74: 665–674.PubMedCrossRef
17.
Zurück zum Zitat Xu, L., X. Chen, M. Shen, D.R. Yang, L. Fang, G. Weng, et al. 2018. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels. Molecular Oncology 12: 269–286.PubMedCrossRef Xu, L., X. Chen, M. Shen, D.R. Yang, L. Fang, G. Weng, et al. 2018. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels. Molecular Oncology 12: 269–286.PubMedCrossRef
18.
Zurück zum Zitat Zhang, N., Y. Zeng, W. Du, J. Zhu, D. Shen, Z. Liu, et al. 2016. The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer. International Journal of Oncology 49: 1360–1368.PubMedCrossRef Zhang, N., Y. Zeng, W. Du, J. Zhu, D. Shen, Z. Liu, et al. 2016. The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer. International Journal of Oncology 49: 1360–1368.PubMedCrossRef
19.
Zurück zum Zitat Gao, X., Y. Li, H. Wang, C. Li, and J. Ding. 2017. Inhibition of HIF-1α decreases expression of pro-inflammatory IL-6 and TNF-α in diabetic retinopathy. Acta Ophthalmologica 95: e746–e750.PubMedCrossRef Gao, X., Y. Li, H. Wang, C. Li, and J. Ding. 2017. Inhibition of HIF-1α decreases expression of pro-inflammatory IL-6 and TNF-α in diabetic retinopathy. Acta Ophthalmologica 95: e746–e750.PubMedCrossRef
20.
Zurück zum Zitat Selvendiran, K., A. Bratasz, M.L. Kuppusamy, M.F. Tazi, B.K. Rivera, and P. Kuppusamy. 2009. Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. International Journal of Cancer 125: 2198–2204.PubMedCrossRef Selvendiran, K., A. Bratasz, M.L. Kuppusamy, M.F. Tazi, B.K. Rivera, and P. Kuppusamy. 2009. Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. International Journal of Cancer 125: 2198–2204.PubMedCrossRef
21.
Zurück zum Zitat Jung, J.E., H.G. Lee, I.H. Cho, D.H. Chung, S.H. Yoon, Y.M. Yang, et al. 2005. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. The FASEB Journal 19: 1296–1298.PubMedCrossRef Jung, J.E., H.G. Lee, I.H. Cho, D.H. Chung, S.H. Yoon, Y.M. Yang, et al. 2005. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. The FASEB Journal 19: 1296–1298.PubMedCrossRef
22.
Zurück zum Zitat Jiang, Q., Z. Chen, and H. Jiang. 2020. Flufenamic acid alleviates sepsis-induced lung injury by up-regulating CBR1. Drug Development Research 81: 885–892.PubMedCrossRef Jiang, Q., Z. Chen, and H. Jiang. 2020. Flufenamic acid alleviates sepsis-induced lung injury by up-regulating CBR1. Drug Development Research 81: 885–892.PubMedCrossRef
23.
Zurück zum Zitat Zhang, Y., J. Li, J. Lou, Y. Zhou, L. Bo, J. Zhu, et al. 2011. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Critical Care (London, England) 15: R70.CrossRef Zhang, Y., J. Li, J. Lou, Y. Zhou, L. Bo, J. Zhu, et al. 2011. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Critical Care (London, England) 15: R70.CrossRef
24.
Zurück zum Zitat Hotchkiss, R., G. Monneret, and D. Payen. 2013. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nature Reviews Immunology 13: 862–874.PubMedCrossRef Hotchkiss, R., G. Monneret, and D. Payen. 2013. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nature Reviews Immunology 13: 862–874.PubMedCrossRef
25.
Zurück zum Zitat Huang, X., F. Venet, Y.L. Wang, A. Lepape, Z. Yuan, Y. Chen, et al. 2009. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proceedings of the National Academy of Sciences of the United States of America 106: 6303–6308.PubMedCrossRef Huang, X., F. Venet, Y.L. Wang, A. Lepape, Z. Yuan, Y. Chen, et al. 2009. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proceedings of the National Academy of Sciences of the United States of America 106: 6303–6308.PubMedCrossRef
26.
Zurück zum Zitat Huang, X., Y. Chen, C.S. Chung, Z. Yuan, S.F. Monaghan, F. Wang, et al. 2014. Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. Journal of Immunology 192: 1091–1099.CrossRef Huang, X., Y. Chen, C.S. Chung, Z. Yuan, S.F. Monaghan, F. Wang, et al. 2014. Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. Journal of Immunology 192: 1091–1099.CrossRef
27.
Zurück zum Zitat Brahmer, J.R., S.S. Tykodi, L.Q. Chow, W.J. Hwu, S.L. Topalian, P. Hwu, et al. 2012. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. The New England Journal of Medicine 366: 2455–2465.PubMedCrossRef Brahmer, J.R., S.S. Tykodi, L.Q. Chow, W.J. Hwu, S.L. Topalian, P. Hwu, et al. 2012. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. The New England Journal of Medicine 366: 2455–2465.PubMedCrossRef
28.
Zurück zum Zitat Hotchkiss, R.S., and L.L. Moldawer. 2014. Parallels between cancer and infectious disease. The New England Journal of Medicine 371: 380–383.PubMedCrossRef Hotchkiss, R.S., and L.L. Moldawer. 2014. Parallels between cancer and infectious disease. The New England Journal of Medicine 371: 380–383.PubMedCrossRef
29.
Zurück zum Zitat Li, X.H., X. Gong, L. Zhang, R. Jiang, H.Z. Li, M.J. Wu, et al. 2013. Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1. Mediators of Inflammation 2013: 354087.PubMedCrossRef Li, X.H., X. Gong, L. Zhang, R. Jiang, H.Z. Li, M.J. Wu, et al. 2013. Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1. Mediators of Inflammation 2013: 354087.PubMedCrossRef
30.
Zurück zum Zitat Zhu, J., J. Wang, Y. Sheng, Y. Zou, L. Bo, F. Wang, et al. 2012. Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis. PLoS One 7: e35523.PubMedCrossRef Zhu, J., J. Wang, Y. Sheng, Y. Zou, L. Bo, F. Wang, et al. 2012. Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis. PLoS One 7: e35523.PubMedCrossRef
31.
Zurück zum Zitat Zhu, W., R. Bao, X. Fan, T. Tao, J. Zhu, J. Wang, et al. 2013. PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model. Mediators of Inflammation 2013: 361501.PubMedCrossRef Zhu, W., R. Bao, X. Fan, T. Tao, J. Zhu, J. Wang, et al. 2013. PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model. Mediators of Inflammation 2013: 361501.PubMedCrossRef
32.
Zurück zum Zitat Kumari, N., B.S. Dwarakanath, A. Das, and A.N. Bhatt. 2016. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biology 37: 11553–11572.PubMedCrossRef Kumari, N., B.S. Dwarakanath, A. Das, and A.N. Bhatt. 2016. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biology 37: 11553–11572.PubMedCrossRef
33.
Zurück zum Zitat Zerdes, I., A. Matikas, J. Bergh, G. Rassidakis, and T. Foukakis. 2018. Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations. Oncogene 37: 4639–4661.PubMedPubMedCentralCrossRef Zerdes, I., A. Matikas, J. Bergh, G. Rassidakis, and T. Foukakis. 2018. Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations. Oncogene 37: 4639–4661.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Miao, D., C.A. Margolis, W. Gao, M.H. Voss, W. Li, D.J. Martini, et al. 2018. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science 359: 801–806.PubMedCrossRef Miao, D., C.A. Margolis, W. Gao, M.H. Voss, W. Li, D.J. Martini, et al. 2018. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science 359: 801–806.PubMedCrossRef
35.
Zurück zum Zitat Wölfle, S., J. Strebovsky, H. Bartz, A. Sähr, C. Arnold, C. Kaiser, et al. 2011. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. European Journal of Immunology 41: 413–424.PubMedCrossRef Wölfle, S., J. Strebovsky, H. Bartz, A. Sähr, C. Arnold, C. Kaiser, et al. 2011. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. European Journal of Immunology 41: 413–424.PubMedCrossRef
36.
Zurück zum Zitat Zhang, W., Y. Liu, Z. Yan, H. Yang, W. Sun, Y. Yao, et al. 2020. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma. Journal for Immunotherapy of Cancer 8: e000285.PubMedCrossRef Zhang, W., Y. Liu, Z. Yan, H. Yang, W. Sun, Y. Yao, et al. 2020. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma. Journal for Immunotherapy of Cancer 8: e000285.PubMedCrossRef
37.
Zurück zum Zitat Liu, Z., R. Xi, Z. Zhang, W. Li, Y. Liu, F. Jin, et al. 2014. 4-Hydroxyphenylacetic acid attenuated inflammation and edema via suppressing HIF-1α in seawater aspiration-induced lung injury in rats. International Journal of Molecular Sciences 15: 12861–12884.PubMedCrossRef Liu, Z., R. Xi, Z. Zhang, W. Li, Y. Liu, F. Jin, et al. 2014. 4-Hydroxyphenylacetic acid attenuated inflammation and edema via suppressing HIF-1α in seawater aspiration-induced lung injury in rats. International Journal of Molecular Sciences 15: 12861–12884.PubMedCrossRef
38.
Zurück zum Zitat Huang, J.J., J. Xia, L.L. Huang, and Y.C. Li. 2019. HIF-1α promotes NLRP3 inflammasome activation in bleomycin-induced acute lung injury. Molecular Medicine Reports 20: 3424–3432.PubMed Huang, J.J., J. Xia, L.L. Huang, and Y.C. Li. 2019. HIF-1α promotes NLRP3 inflammasome activation in bleomycin-induced acute lung injury. Molecular Medicine Reports 20: 3424–3432.PubMed
39.
Zurück zum Zitat Noman, M.Z., G. Desantis, B. Janji, M. Hasmim, S. Karray, P. Dessen, et al. 2014. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. The Journal of Experimental Medicine 211: 781–790.PubMedCrossRef Noman, M.Z., G. Desantis, B. Janji, M. Hasmim, S. Karray, P. Dessen, et al. 2014. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. The Journal of Experimental Medicine 211: 781–790.PubMedCrossRef
40.
Zurück zum Zitat Mittendorf, E.A., A.V. Philips, F. Meric-Bernstam, N. Qiao, Y. Wu, S. Harrington, et al. 2014. PD-L1 expression in triple-negative breast cancer. Cancer Immunology Research 2: 361–370.PubMedCrossRef Mittendorf, E.A., A.V. Philips, F. Meric-Bernstam, N. Qiao, Y. Wu, S. Harrington, et al. 2014. PD-L1 expression in triple-negative breast cancer. Cancer Immunology Research 2: 361–370.PubMedCrossRef
41.
Zurück zum Zitat Soliman, H., F. Khalil, and S. Antonia. 2014. PD-L1 expression is increased in a subset of basal type breast cancer cells. PLoS One 9: e88557.PubMedCrossRef Soliman, H., F. Khalil, and S. Antonia. 2014. PD-L1 expression is increased in a subset of basal type breast cancer cells. PLoS One 9: e88557.PubMedCrossRef
Metadaten
Titel
PD-L1 Regulates Inflammation in LPS-Induced Lung Epithelial Cells and Vascular Endothelial Cells by Interacting with the HIF-1α Signaling Pathway
verfasst von
Shilong Zhao
Jing Gao
Jing Li
Shilei Wang
Congcong Yuan
Qiuhong Liu
Publikationsdatum
20.05.2021
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2021
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-021-01474-3

Weitere Artikel der Ausgabe 5/2021

Inflammation 5/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.